ask="5.090"
ask_size="2000"
average_daily_volume="1509150"
bid="4.740"
bid_size="1000"
book_value="0.208"
change="-0.335"
change_from_200_day_moving_average="-0.550"
change_from_50_day_moving_average="-1.023"
change_from_52_week_high="-2.905"
change_From_52_week_low="1.785"
change_in_percent="-6.405%"
close="4.895"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.563"
ebitda="-113.37M"
eps_estimate_current_year="-1.450"
eps_estimate_next_quarter="-0.190"
eps_estimate_next_year="-0.610"
ex_dividend_date="N/A"
float_shares="71243000"
high="5.250"
high_52_weeks="7.800"
last_trade_date="1/24/2017"
last_trade_price="4.895"
last_trade_size="58232"
last_trade_time="4:00pm"
low="4.760"
low_52_weeks="3.110"
market_capitalization="518.67M"
moving_average_200_day="5.445"
moving_average_50_day="5.918"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.210"
open="5.220"
pe_ratio="N/A"
peg_ratio="-0.030"
percent_change_from_200_day_moving_average="-10.102%"
percent_change_from_50_day_moving_average="-17.293%"
percent_change_from_52_week_high="-37.244%"
percent_change_from_52_week_low="+57.396%"
previous_close="5.230"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="25.144"
price_per_sales="19.628"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="16.170"
stock_exchange="NCM"
symbol="KERX"
volume="2905987"
weeks_range_52="3.110 - 7.800"
